DailyIQ
Last updated 4 minutes ago

WRB·W. R. Berkley Corporation

$.
+. (+.%)
After Hours
High
$72.22
Open
$71.76
Market Cap
26.97B
52W High
$78.96
Low
$71.59
P. Close
$72.18
P/E
14.37
52W Low
$62.87
Fwd P/E
15.07
DailyIQ Est.
$63.86
Technical Score (1D)
95
BUY
News Sentiment
47
MIXED
Evercore ISI Group kept its Underperform rating on WR Berkley while raising the price target to $68, signaling a modest upside expectation despite a negative outlook. Wells Fargo likewise maintained an Underweight stance and lifted its target to $67, underscoring confidence in the insurer’s underwriting performance and capital structure. Cantor Fitzgerald held a Neutral rating and increased the target to $74, reflecting optimism about premium growth in specialty lines. UBS and Mizuho both raised their targets to $71 and $72 respectively while keeping hold ratings, indicating a more favorable view amid stable earnings. These concurrent upgrades suggest that analysts see potential for earnings improvement, yet the negative or neutral ratings temper short‑term sentiment. The upcoming Q2 earnings release next month will be the key catalyst to confirm whether the modest upside expectations materialize. In addition, WRB’s share price has recently crossed its 200‑day moving average, a bullish technical signal that may attract new buyers if earnings support the trend. The company’s recent dividend hike and buyback reset, coupled with an AM Best credit upgrade, reinforce its financial strength and could lower borrowing costs, potentially supporting future underwriting growth. Traders should watch the earnings report for loss ratios and capital allocation, monitor volume around the 200‑day SMA, and keep an eye on any regulatory changes that could affect specialty lines.
Earnings Summary
W.R. Berkley Corporation is a global insurance holding company that focuses on commercial lines insurance, operating through its Insurance and Reinsurance & Monoline Excess segments; it serves a diverse set of industries with excess, surplus, specialty personal, and accident and health products, positioning it within the broader financial services sector. In the most recent reporting period, the company posted earnings per share of $1.30 in Q1 2026, beating the $1.1592 estimate, while revenue of $3.70611 billion fell slightly below the $3.7965 billion estimate, indicating a modest revenue deceleration after a 1.7% increase from Q4 2025. The Q4 2025 quarter saw revenue of $3.71548 billion, surpassing the $3.6971 billion estimate, but EPS of $1.13 missed the $1.1383 forecast, underscoring a mixed earnings trend; overall, the company has beaten EPS estimates in four of the last six quarters, while revenue has generally trended upward despite occasional misses. Historically, W.R. Berkley has delivered a strong YoY revenue growth of roughly 23% from Q4 2024 to Q4 2025, while EPS growth has been more modest, hovering near flat levels; the insurer has consistently outperformed analyst expectations on earnings, even as it has occasionally missed revenue targets, suggesting resilience in underwriting profitability. Recent analyst commentary highlights a series of price target upgrades—from $58 to $67 by Wells Fargo, to $74 by Cantor Fitzgerald, and $71–$72 by UBS and Mizuho—reflecting confidence in premium growth and capital structure, while the company’s dividend hike, buyback reset, and AM Best credit upgrade reinforce its financial strength; these developments coincide with the stock’s crossing of its 200‑day moving average, a bullish technical signal. Investors should watch the forthcoming Q2 2026 earnings release for updated loss ratios, capital allocation decisions, and any regulatory changes that could impact specialty lines, as well as any adjustments to the dividend policy, as these factors will be key to confirming the optimistic outlook suggested by the recent analyst upgrades.

EPS

EstBeatMiss
$0.94$1.04$1.14$1.25$1.35Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.09 - -
Q1'26$1.16$1.30+12.1%
Q4'25$1.14$1.13-0.7%
Q3'25$1.10$1.10-0.3%
Q2'25$1.02$1.05+2.5%
Q1'25$0.99$1.01+2.4%

Revenue

EstBeatMiss
$2.9B$3.2B$3.4B$3.7B$3.9BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$3.8B - -
Q1'26$3.8B$3.7B-2.4%
Q4'25$3.7B$3.7B+0.5%
Q3'25 - $3.2B -
Q2'25 - $3.1B -
Q1'25 - $3.0B -

Market Data

WRB Stock Snapshot

WRB is currently trading at $72.19, giving W. R. Berkley Corporation a market cap of 26.97B and a P/E ratio of 14.4. Today's range spans $71.59–$72.22, with shares opening at $71.76 and moving up $0.01 (0.0%) from the prior close. DailyIQ's technical score sits at 95/100 (BUY) with a news sentiment reading of 47/100.

Over the past year WRB has traded between $62.87 and $78.96 - the current price is +14.8% off the 52-week low and -8.6% from the high. 29 analysts cover the stock with a Hold consensus and a mean 12-month target of $67.24 (range $51.00–$78.00), implying downside of -6.9%.

In the Financial Services peer group, W. R. Berkley Corporation (WRB) stands out for a BUY signal backed by aligned sentiment - score 95/100, sentiment neutral at 47/100, price $72.19 (in the middle of its 52-week range). (P/E: 14.4) With 26.97B in market cap, this is large enough to feature on institutional watch lists but small enough to re-rate meaningfully on a positive earnings surprise. The 52-week span of $62.87–$78.96 shows the stock has already proven it can make significant moves.

The combination of a BUY signal (95/100) and neutral news sentiment (47/100) puts WRB on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 26.97B in Financial Services market cap without immediately moving the stock. At $72.19 (in the middle of its 52-week range in the $62.87–$78.96 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.